arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2302.11546physics.med-ph
收藏

一种使用稀疏滤波器求解质子FLASH治疗IPO-IMPT的新型逆向算法

A novel inverse algorithm to solve IPO-IMPT of proton FLASH therapy with sparse filters

Nathan Harrison, Minglei Kang, Ruirui Liu, Serdar Charyyev, Niklas Wahl, Wei Liu, Jun Zhou, Kristin A. Higgins, Charles Simone, Jeffrey Bradley, William S. Dynan, Liyong Lin

AI总结:

本文提出基于分布式计算的逆向SIEMAC算法,联合优化稀疏射程补偿、调制与点强度,显著提升肺癌患者剂量率覆盖并降低LET,同时改善小型猪实验分布精度。

摘要:

目的:最近提出的IPO-IMPT框架允许在FLASH治疗计划中同时优化剂量、剂量率和LET。由于计算量大,找到IPO-IMPT的解决方案十分困难。尽管如此,能够同时确定稀疏滤波器几何结构和质子强度图权重的逆向解决方案,对于临床和临床前应用都具有重要价值。此类解决方案可以降低癌症患者危及器官的有效生物剂量,并减少临床前研究中为获得额外生物剂量模型所需的动物照射次数。方法:与我们最初的正向启发式方法不同,该逆向IPO-IMPT解决方案包括对稀疏射程补偿、稀疏射程调制和点强度进行同时优化。通过分布式计算框架迭代解决了这项工作中至关重要的艰巨计算任务,从而实现同步强度与能量调制及补偿(SIEMAC)。SIEMAC在一名人类肺癌患者和一只小型猪上进行了演示。结果:SIEMAC改进了点强度图以及针对患者射野的稀疏射程补偿器和射程调制器。对于肺癌患者,在我们300 nA的最大喷嘴电流下,肺部高于100 Gy/s的剂量率覆盖率从57%提高到96%,心脏从93%提高到100%;肺部高于4 keV/μm的LET覆盖率从68%降至9%,心脏从26%降至<1%。对于一个简单的小型猪计划,剂量、剂量率和LET分布的FWHM分别降低了30%、1.6%和57%,同时保持相似的靶区剂量覆盖率,从而降低了临床前研究中这些量的不确定性。结论:IPO-IMPT的逆向解决方案证明了其能够为临床和临床前研究同时调制子点质子能量和强度分布。

英文摘要:

Purpose:The recently proposed IPO-IMPT framework allows simultaneous optimization of dose, dose rate, and LET for FLASH treatment planning. Finding solutions to IPO-IMPT is difficult due to computational intensiveness. Nevertheless, an inverse solution that simultaneously specifies the geometry of a sparse filter and weights of a proton intensity map is desirable for both clinical and preclinical applications. Such solutions can reduce effective biological dose to organs at risk in cancer patients as well as reduce the number of animal irradiations needed to derive extra biological dose models in preclinical studies. Methods:Unlike our initial forward heuristic, this inverse IPO-IMPT solution includes simultaneous optimization of sparse range compensation, sparse range modulation, and spot intensity. The daunting computational tasks vital to this endeavor were resolved iteratively with a distributed computing framework to enable Simultaneous Intensity and Energy Modulation and Compensation (SIEMAC). SIEMAC was demonstrated on a human lung cancer patient and a minipig. Results:SIEMAC improves maps of spot intensities and patient-field-specific sparse range compensators and range modulators. For the lung cancer patient, at our max nozzle current of 300 nA, dose rate coverage above 100 Gy/s increased from 57% to 96% in the lung and from 93% to 100% in the heart, and LET coverage above 4 keV/um dropped from 68% to 9% in the lung and from 26% to <1% in the heart. For a simple minipig plan, the FWHM of the dose, dose rate, and LET distributions decreased by 30%, 1.6%, and 57%, respectively, again with similar target dose coverage, thus reducing uncertainty in these quantities for preclinical studies. Conclusion:The inverse solution to IPO-IMPT demonstrated the capability to simultaneously modulate sub-spot proton energy and intensity distributions for clinical and preclinical studies.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑